boehringer_ingelheim (biotechcompany)
literal strings:
Boehringer-Ingelheim, BOEHRINGER INGELHEIM, Boehringer Ingelheim, boehringer ingelheim
boehringer ingelheim pharmaceuticals, Boehringer-Ingelheim Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals
Help NELL Learn!
NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.
categories
- biotechcompany(100.0%)
- CMC @1087 (100.0%) on 20-dec-2017 [ PREFIX=boe 4.44343 PREFIX=in 2.85346 LASTPREFIX=in 2.43182 CHARS 1.19812 PREFIX=bo 1.02558 SUFFIX=ger 0.64604 SUFFIX=nger 0.64198 FULL_WORDSHAPE=a_a -0.47135 FULL_POS=NN_NN -1.58892 WORDS -2.74416 ] using boehringer_ingelheim
- CPL @1109 (59.3%) on 12-jun-2018 [ "educational grant provided by _" "_ holds the patent" "pharmaceutical company called _" "trial was sponsored by _" "drug is marketed by _" "Drug companies like _" "_ is a global pharmaceutical company" "survey , sponsored by _" "pharmaceutical companies including _" "several pharmaceutical companies including _" "registered brand name of _" "drug discovery alliance with _" "drug was developed by _" "discovery collaborations with _" "grant/research support from _" "honorarium from _" "medicinal chemist at _" "medications manufactured by _" "drug made by _" "unrestricted research grant from _" "drug , manufactured by _" "drug is made by _" "educational grants provided by _" "speaker honoraria from _" "unconditional educational grant from _" "unrestricted grant from _" "clinical trial was sponsored by _" "drug companies like _" "animal health division of _" "grant support from _" "new vaccine from _" "unconditional grant from _" "speakers bureau for _" "travel assistance from _" "you purchase is manufactured by _" "medicinal chemistry at _" "trial sponsored by _" "Prize , sponsored by _" "patent held by _" "several pharmaceutical companies , including _" "drug sold by _" "AB-rated generic equivalent of _" "_ acquired the drug" "medication you purchase is manufactured by _" "chemical manufactured by _" "pharmaceutical companies , such as _" "drug developed by _" "pharmaceutical companies , including _" "collaboration deal with _" "It is manufactured by _" "pharmaceutical company such as _" "drug is manufactured by _" "discovery collaboration with _" "biotechnology companies like _" "educational grant from _" "unrestricted research grants from _" "research grant support from _" "pharmaceutical companies such as _" "unrestricted educational grants from _" "trial was funded by _" "drug manufactured by _" "educational grants from _" "It is marketed by _" "_ 's protease inhibitor" "_ 's oncology pipeline" "educational grant by _" "_ is a pharmaceutical company" "independent educational grants from _" "independent educational grant from _" "_ has exclusive worldwide rights" "kit was purchased from _" "speaker fees from _" "drug discovery collaboration with _" "pharmaceutical sales representative for _" "clinical development at _" "clinical trial sponsored by _" "study was sponsored by _" "major pharmaceutical companies including _" "major pharmaceutical companies , including _" "_ immediately cease the dissemination" "drug produced by _" "drug company called _" "_ 's executive management" "various pharmaceutical companies , including _" "honorariums from _" "research support from _" "brand name owned by _" "milestone payment from _" "tablets manufactured by _" "honoraria from _" "MigreLieve , made by _" "pharmaceutical companies like _" "FDA instructed _" "milestone payments from _" "experimental drug from _" "inhibitor developed by _" "unrestricted educational grant from _" "medication is made by _" "co-marketing agreement with _" "large pharmaceutical companies such as _" "speakersbureau for _" "discovery alliance with _" "consulting fees from _" "speaker bureau for _" "inhibitor made by _" "_ 's new vaccine" "DEA has investigated _" "salary/honoraria from _" "collaboration agreement with _" "lecture fees from _" "unrestricted grants from _" ] using boehringer_ingelheim
- CPL @1105 (72.8%) on 25-mar-2018 [ "speaker honoraria from _" "educational grant from _" "pharmaceutical sales representative with _" "pharmaceutical companies including _" "unrestricted educational grant from _" "honoraria from _" ] using boehringer_ingelheim_pharmaceuticals
- OE @925 (100.0%) on 15-may-2015 [ https://www.linkedin.com/company/boehringer-ingelheim ] using boehringer_ingelheim
- SEAL @211 (87.5%) on 17-feb-2011 [ 1 2 3 ] using boehringer_ingelheim_pharmaceuticals
- OE @1033 (100.0%) on 25-dec-2016 [ http://www.newstimes.com/business/article/Boehringer-Ingelheim-At-least-200M-in-upgrades-6305089.php http://www.prnewswire.com/news-releases/pradaxa-maker-boehringer-ingelheim-pharmaceuticals-pursues-pradaxa-fda-approval-to-treat-dvt-and-pe-300068838.html https://en.wikipedia.org/wiki/Boehringer_Ingelheim https://en.wikipedia.org/wiki/Boehringer_Ingelheim http://www.drugs.com/manufacturer/boehringer-ingelheim-pharmaceuticals-inc-31.html ] using boehringer_ingelheim_pharmaceuticals
- SEAL @209 (99.9%) on 14-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 ] using boehringer_ingelheim
- CMC @841 (100.0%) on 25-may-2014 [ PREFIX=in 1.73271 PREFIX=boe 1.51426 SHORT_WORDSHAPE=Aa 1.19456 SUFFIX=icals 1.03783 SUFFIX=cals 1.03764 SUFFIX=als 0.99092 PREFIX=pha 0.98313 CHARS -1.94872 SHORT_WORDSHAPE=a -2.71639 WORDS -2.96883 ] using boehringer_ingelheim_pharmaceuticals
- company(100.0%)
NELL has only weak evidence for items listed in grey
- hospital
- SEAL @224 (50.0%) on 24-mar-2011 [ 1 ] using boehringer_ingelheim
relations
- agentworkedondrug
- meloxicam (100.0%)
- OE @832 (100.0%) on 18-apr-2014 [ ] using (meloxicam, boehringer_ingelheim)
- SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (meloxicam, boehringer_ingelheim)
- nevirapine (100.0%)
- OE @803 (85.5%) on 13-jan-2014 [ ] using (nevirapine, boehringer_ingelheim)
- SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (nevirapine, boehringer_ingelheim)
- mobic (98.4%)
- SEAL @241 (50.0%) on 22-apr-2011 [ 1 ] using (mobic, boehringer_ingelheim_pharmaceuticals)
- SEAL @269 (87.5%) on 24-may-2011 [ 1 2 3 ] using (mobic, boehringer_ingelheim)
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is being manufactured by arg2" "arg1 is manufactured by arg2" ] using (mobic, boehringer_ingelheim_pharmaceuticals)
- spiriva (96.9%)
- CPL @1103 (50.0%) on 06-mar-2018 [ "arg1 was discovered and developed by arg2" ] using (spiriva, boehringer_ingelheim)
- SEAL @305 (93.8%) on 19-jun-2011 [ 1 2 3 4 ] using (spiriva, boehringer_ingelheim)
- SEAL @241 (50.0%) on 22-apr-2011 [ 1 ] using (spiriva, boehringer_ingelheim_pharmaceuticals)
- micardis (93.8%)
- SEAL @241 (50.0%) on 22-apr-2011 [ 1 ] using (micardis, boehringer_ingelheim_pharmaceuticals)
- SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (micardis, boehringer_ingelheim)
- CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 is manufactured by arg2" ] using (micardis, boehringer_ingelheim)
- viramune (93.8%)
- CPL @1103 (50.0%) on 06-mar-2018 [ "arg1 is marketed by arg2" ] using (viramune, boehringer_ingelheim)
- SEAL @263 (87.5%) on 22-may-2011 [ 1 2 3 ] using (viramune, boehringer_ingelheim)
- CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 XR is made by arg2" ] using (viramune, boehringer_ingelheim_pharmaceuticals)
- hasofficeincity
- ridgefield (93.8%)
- SEAL @35 (93.8%) on 27-jan-2010 [ 1 2 3 4 ] using (boehringer_ingelheim_pharmaceuticals, ridgefield)
- organizationheadquarteredincity
- ridgefield (100.0%)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:hasofficeincity" "Y~X0~concept:hasofficeincity" "Y~_X0~concept:hasofficeincity,concept:cityhascompanyoffice,concept:hasofficeincity" "Y~_X0~concept:hasofficeincity,concept:cityhascompanyoffice,concept:organizationactsinlocation" "Y~_X0~concept:hasofficeincity,concept:cityhascompanyoffice,concept:agentactsinlocation" ] using (boehringer_ingelheim_pharmaceuticals, ridgefield)
- OE @1033 (100.0%) on 25-dec-2016 [ http://www.prnewswire.com/news-releases/qualcomm-and-boehringer-ingelheim-pharmaceuticals-collaborate-to-add-new-digital-technology-to-respimat-inhaler-300319785.html http://www.qualcommlife.com/press-releases/item/august-30-2016-qualcomm-and-boehringer-ingelheim-pharmaceuticals-collaborate-to-add-new-digital-technology-to-respimat-inhaler https://en.wikipedia.org/wiki/Boehringer_Ingelheim ] using (boehringer_ingelheim_pharmaceuticals, ridgefield)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:hasofficeincity" "Y~X0~concept:hasofficeincity" "Y~_X0~concept:hasofficeincity,concept:cityhascompanyoffice,concept:hasofficeincity" "Y~_X0~concept:hasofficeincity,concept:cityhascompanyoffice,concept:organizationactsinlocation" "Y~_X0~concept:hasofficeincity,concept:cityhascompanyoffice,concept:agentactsinlocation" ] using (boehringer_ingelheim, ridgefield)
NELL has only weak evidence for items listed in grey
- agentworkedondrug
- bisolvon
- SEAL @269 (50.0%) on 24-may-2011 [ 1 ] using (bisolvon, boehringer_ingelheim)
- buscopan
- SEAL @263 (50.0%) on 22-may-2011 [ 1 ] using (buscopan, boehringer_ingelheim)
- dulcolax
- SEAL @523 (50.0%) on 02-mar-2012 [ 1 ] using (dulcolax, boehringer_ingelheim)
- metalyse
- SEAL @269 (50.0%) on 24-may-2011 [ 1 ] using (metalyse, boehringer_ingelheim)
- persantin
- SEAL @269 (50.0%) on 24-may-2011 [ 1 ] using (persantin, boehringer_ingelheim)
- geopoliticallocationcontainsstate
- states
- CPL @1112 (50.0%) on 20-jul-2018 [ "arg2 and in the United arg1" ] using (states, boehringer_ingelheim)
- hasofficeincity
- germany (country)
- CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 Corporate Headquarters in arg2" ] using (boehringer_ingelheim, germany)
- germany (sportsteam)
- CPL @1100 (50.0%) on 31-jan-2018 [ "arg1 Corporate Headquarters in arg2" ] using (boehringer_ingelheim, germany)
- organizationheadquarteredincity
- germany (country)
- CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 Corporate Headquarters in arg2" ] using (boehringer_ingelheim, germany)
- connecticut (geopoliticallocation)
- CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 corporate campus in arg2" ] using (boehringer_ingelheim, connecticut)
- germany (sportsteam)
- CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 Corporate Headquarters in arg2" ] using (boehringer_ingelheim, germany)
- connecticut (stateorprovince)
- CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 corporate campus in arg2" ] using (boehringer_ingelheim, connecticut)
- connecticut (university)
- CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 corporate campus in arg2" ] using (boehringer_ingelheim, connecticut)
